27 results
424B3
SLGL
Sol-Gel Technologies Ltd
4 Apr 24
Prospectus supplement
9:05am
Authority for Technological Innovation (previously known as the Israeli Office of the Chief Scientist), or the IIA, for approval to allow a tax
POS AM
SLGL
Sol-Gel Technologies Ltd
20 Mar 24
Prospectus update (post-effective amendment)
4:05pm
apply to the National Authority for Technological Innovation (previously known as the Israeli Office of the Chief Scientist), or the IIA, for approval
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
8 Jun 22
Current report (foreign)
7:15am
following first sale at no cost Cash-flow positive deal as of launch Allows for focus on innovative pipeline
IMPLEMENTING INNOVATION Enabling
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
16 May 22
Current report (foreign)
7:35am
first sale at no cost Cash-flow positive deal as of launch Allows for focus on innovative pipeline
IMPLEMENTING INNOVATION Enabling
6-K
EX-1.1
pnjv y3cy9
19 Apr 22
Open Market Sale Agreementsm
4:05pm
424B5
b2jh rzol7c
19 Apr 22
Prospectus supplement for primary offering
4:02pm
20-F/A
btqawf5 5bvwqh9j5
7 Apr 22
Annual report (foreign) (amended)
4:06pm
6-K
EX-99.1
xqgwcscbt3aw9
16 Nov 21
Current report (foreign)
4:05pm
6-K
EX-99.1
edxat2 146hwkfxwe3w
27 Jul 21
TWYNEO®, a once-daily cream treatment for acne vulgaris, is the first FDA‑approved fixed‑dose combination of tretinoin and benzoyl peroxide
10:39am
6-K
EX-99.1
xv6iz9jn
28 Jun 21
Sol-Gel Technologies and Galderma announce exclusive licenses for the About Papulopustular Rosacea
8:14am
6-K
EX-99.1
m1v8a45a
18 Feb 21
Current report (foreign)
1:20pm
6-K
EX-1.1
xfb4ks 1ov
14 Feb 20
Sol-Gel Announces Pricing of Public Offering of Ordinary Shares and Warrants to Purchase
5:24pm
424B5
onxfxq
13 Feb 20
Prospectus supplement for primary offering
9:57pm
6-K
EX-99.1
e8t7n zd6p4alb769sm
5 Feb 20
Current report (foreign)
3:38pm
6-K
EX-1.1
gbndnolka5wt7qe
13 Jan 20
Current report (foreign)
12:00am
424B5
v7w 4m1wi9hz
10 Jan 20
Prospectus supplement for primary offering
5:06pm